Ventricular assist device has rapidly emerged as a durable and safe therapy for end-stage
heart failure patients with> 22 000 implantations to date. Though originally conceived for …

Left ventricular assist devices are becoming an increasingly prevalent therapy for patients
with Stage D heart failure with reduced ejection fraction. Technological advances have …

Pulmonary hypertension associated with left heart disease is the most common form of
pulmonary hypertension encountered in clinical practice today. Although frequently a target …

Heart failure is a progressive disease that now affects 5 million patients in the United States.
Recent estimates suggest that between 5% and 10% of all patients with heart failure (HF) …

Acute right ventricular (RV) failure is a frequent and serious clinical challenge in the
intensive care unit. It is usually seen as a consequence of left ventricular failure, pulmonary …

Objective: Conflicting data still exist concerning the reversibility of secondary severe
'fixed'pulmonary hypertension (PH) by the use of left ventricular assist device (LVAD) …

Primary graft failure (PGF) is a devastating complication that occurs in the immediate
postoperative period following heart transplantation. It manifests as severe ventricular …

Does the heart transplant have a future? - PMC Back to Top Skip to main content NIH NLM Logo
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview …

Congestive heart failure (HF) remains a serious burden in the Western World. Despite
advances in pharmacotherapy and resynchronization, many patients have progression to …

Left heart disease (LHD) represents the most common causes of pulmonary hypertension
(PH). Whether caused by systolic or diastolic dysfunction or valvular heart disease, a …